288 related articles for article (PubMed ID: 30619347)
41. Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH; Prohaska SS; Santoro JC; Robinson HL; Parnes JR
J Immunol; 1995 Nov; 155(10):4739-48. PubMed ID: 7594475
[TBL] [Abstract][Full Text] [Related]
42. CD6 modulates thymocyte selection and peripheral T cell homeostasis.
Orta-Mascaró M; Consuegra-Fernández M; Carreras E; Roncagalli R; Carreras-Sureda A; Alvarez P; Girard L; Simões I; Martínez-Florensa M; Aranda F; Merino R; Martínez VG; Vicente R; Merino J; Sarukhan A; Malissen M; Malissen B; Lozano F
J Exp Med; 2016 Jul; 213(8):1387-97. PubMed ID: 27377588
[TBL] [Abstract][Full Text] [Related]
43. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
44. Ablation of core fucosylation attenuates the signal transduction via T cell receptor to suppress the T cell development.
Liang W; Mao S; Li M; Zhang N; Sun S; Fang H; Zhang J; Gu J; Wang J; Li W
Mol Immunol; 2019 Aug; 112():312-321. PubMed ID: 31229844
[TBL] [Abstract][Full Text] [Related]
45. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
46. Does co-aggregation of the CD45 and CD3 antigens inhibit T cell antigen receptor complex-mediated activation of phospholipase C and protein kinase C?
Shivnan E; Biffen M; Shiroo M; Pratt E; Glennie M; Alexander D
Eur J Immunol; 1992 Apr; 22(4):1055-62. PubMed ID: 1532359
[TBL] [Abstract][Full Text] [Related]
47. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation.
Hale LP; Haynes BF
J Immunol; 1992 Dec; 149(12):3809-16. PubMed ID: 1281188
[TBL] [Abstract][Full Text] [Related]
48. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
Le Dantec C; Alonso R; Fali T; Montero E; Devauchelle V; Saraux A; Pers JO; Renaudineau Y
Immunol Res; 2013 Jul; 56(2-3):341-7. PubMed ID: 23576060
[TBL] [Abstract][Full Text] [Related]
49. Genomic organization of the human CD5 gene.
Padilla O; Calvo J; Vilà JM; Arman M; Gimferrer I; Places L; Arias MT; Pujana MA; Vives J; Lozano F
Immunogenetics; 2000 Oct; 51(12):993-1001. PubMed ID: 11061284
[TBL] [Abstract][Full Text] [Related]
50. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
51. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex.
Davies AA; Ley SC; Crumpton MJ
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6368-72. PubMed ID: 1378627
[TBL] [Abstract][Full Text] [Related]
52. T Cell Costimulation by CD6 Is Dependent on Bivalent Binding of a GADS/SLP-76 Complex.
Breuning J; Brown MH
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28289074
[TBL] [Abstract][Full Text] [Related]
53. CD6-ligand interactions: a paradigm for SRCR domain function?
Aruffo A; Bowen MA; Patel DD; Haynes BF; Starling GC; Gebe JA; Bajorath J
Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
[TBL] [Abstract][Full Text] [Related]
54. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
Suthanthiran M
J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
[TBL] [Abstract][Full Text] [Related]
55. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
56. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.
Singer NG; Mitra R; Lialios F; Richardson BC; Marks RM; Pesando JM; Fox DA; Nickoloff BJ
Immunol Lett; 1997 Jun; 58(1):9-14. PubMed ID: 9436462
[TBL] [Abstract][Full Text] [Related]
57. The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation.
Do JS; Arribas-Layton D; Juan J; Garcia I; Saraswathy S; Qi M; Montero E; Reijonen H
J Autoimmun; 2024 Jun; 146():103228. PubMed ID: 38642507
[TBL] [Abstract][Full Text] [Related]
58. CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation.
Matson CA; Choi S; Livak F; Zhao B; Mitra A; Love PE; Singh NJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14342-14353. PubMed ID: 32513716
[TBL] [Abstract][Full Text] [Related]
59. Mutational analysis of the CD6 ligand binding domain.
Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
[TBL] [Abstract][Full Text] [Related]
60. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
